Stock Photo - A view of the production facility of pharmaceutical company GlaxoSmithKline Biologicals NL of SmithKline Beecham Pharma GmbH & Co. KG (GSK) in Dresden, Germany, 23 October 2014. GSK has increased its earnings in the third quarter of the 2014 business year in comparison to 2013, due to its rigid austerity measures. The company is currently working on the development of a vaccine against the Ebola virus, which the company stated is still at an early stage. Photo: Arno Burgi/dpa | usage worldwide. - Dresden/Saxony/Germany

Stock Photo: A view of the production facility of pharmaceutical company GlaxoSmithKline Biologicals NL of SmithKline Beecham Pharma GmbH & Co.

Searchable keywords

Choose multiple keywords